Two Sigma Advisers’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-151,335
Closed -$1.73M 2196
2025
Q4
$1.73M Buy
151,335
+2,300
+2% +$27K ﹤0.01% 1243
2025
Q3
$1.89M Buy
149,035
+800
+0.5% +$11.6K ﹤0.01% 1155
2025
Q2
$2.35M Buy
148,235
+6,900
+5% +$103K ﹤0.01% 1039
2025
Q1
$2.11M Buy
141,335
+9,900
+8% +$175K ﹤0.01% 1136
2024
Q4
$2.49M Buy
131,435
+400
+0.3% +$8.46K 0.01% 1022
2024
Q3
$3.55M Buy
131,035
+38,900
+42% +$993K 0.01% 827
2024
Q2
$2.3M Sell
92,135
-11,200
-11% -$321K 0.01% 1114
2024
Q1
$3.43M Sell
103,335
-8,700
-8% -$297K 0.01% 951
2023
Q4
$3.99M Sell
112,035
-9,700
-8% -$308K 0.01% 912
2023
Q3
$4.16M Sell
121,735
-38,800
-24% -$1.48M 0.01% 825
2023
Q2
$6.42M Sell
160,535
-51,900
-24% -$2.06M 0.02% 660
2023
Q1
$8.34M Sell
212,435
-5,500
-3% -$202K 0.02% 611
2022
Q4
$6.94M Sell
217,935
-499,300
-70% -$15.1M 0.02% 639
2022
Q3
$20.3M Sell
717,235
-715,600
-50% -$24.5M 0.06% 317
2022
Q2
$51.2M Sell
1,432,835
-7,300
-0.5% -$295K 0.15% 156
2022
Q1
$70.9M Buy
1,440,135
+1,268,700
+740% +$67.1M 0.19% 118
2021
Q4
$9.56M Sell
171,435
-703,490
-80% -$38.7M 0.02% 510
2021
Q3
$50.8M Buy
874,925
+543,700
+164% +$33.5M 0.13% 153
2021
Q2
$21M Buy
331,225
+147,190
+80% +$9.69M 0.06% 326
2021
Q1
$11.7M Sell
184,035
-30,800
-14% -$1.79M 0.03% 515
2020
Q4
$11.2M Sell
214,835
-78,600
-27% -$3.88M 0.03% 531
2020
Q3
$12.8M Sell
293,435
-11,200
-4% -$495K 0.04% 455
2020
Q2
$13.4M Sell
304,635
-1,800
-0.6% -$76.1K 0.04% 447
2020
Q1
$11.9M Buy
306,435
+66,300
+28% +$3.38M 0.05% 429
2019
Q4
$13.6M Buy
240,135
+171,100
+248% +$9.54M 0.03% 490
2019
Q3
$3.68M Buy
69,035
+57,952
+523% +$3.11M 0.01% 874
2019
Q2
$647K Sell
11,083
-18,794
-63% -$1.01M ﹤0.01% 1705
2019
Q1
$1.48M Sell
29,877
-3,052
-9% -$134K ﹤0.01% 1350
2018
Q4
$1.23M Sell
32,929
-12,655
-28% -$461K ﹤0.01% 1388
2018
Q3
$1.72M Buy
+45,584
New +$1.9M ﹤0.01% 1304
2018
Q2
Sell
-22,894
Closed -$1.15M 2516
2018
Q1
$1.15M Buy
+22,894
New +$1.35M ﹤0.01% 1487
2017
Q2
Sell
-425,180
Closed -$26.5M 2428
2017
Q1
$26.5M Buy
+425,180
New +$25.6M 0.09% 294
2016
Q3
Sell
-12,718
Closed -$789K 2337
2016
Q2
$789K Sell
12,718
-1,231,309
-99% -$75.8M ﹤0.01% 1286
2016
Q1
$76.7M Buy
1,244,027
+801,972
+181% +$47.3M 0.43% 56
2015
Q4
$26.9M Buy
442,055
+234,196
+113% +$13.9M 0.16% 157
2015
Q3
$10.5M Buy
+207,859
New +$11.1M 0.07% 324
2015
Q2
Sell
-28,146
Closed -$1.43M 2101
2015
Q1
$1.43M Buy
28,146
+23,600
+519% +$1.22M 0.01% 919
2014
Q4
$242K Buy
+4,546
New +$231K ﹤0.01% 2093
2014
Q3
Sell
-66,246
Closed -$3.14M 2714
2014
Q2
$3.14M Sell
66,246
-12,100
-15% -$563K 0.02% 619
2014
Q1
$3.61M Buy
+78,346
New +$3.63M 0.03% 536

Other funds holding XRAY

Two Sigma Advisers's XRAY Position: Q1 2026 in Review

Two Sigma Advisers sold out of Dentsply Sirona (XRAY) in Q1 2026, closing a stake of 151,335 shares — an estimated $1.73M sold.

Two Sigma Advisers first reported a position in XRAY in Q1 2014 and held it in 40 quarters. The position peaked at $76.7M in Q1 2016. 382 funds tracked by Wall St. Rank hold XRAY as of Q1 2026.

  • Two Sigma Advisers reported no remaining Dentsply Sirona position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 151,335 Dentsply Sirona shares in Q1 2026, an estimated $1.73M.
  • Two Sigma Advisers first reported a position in Dentsply Sirona in Q1 2014 and held it in 40 quarters.
  • Two Sigma Advisers's Dentsply Sirona position peaked at $76.7M in Q1 2016.
  • 382 funds tracked by Wall St. Rank held Dentsply Sirona as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.